Passive immunotherapies for COVID-19: The subtle line between standard and hyperimmune immunoglobulins is getting invisible.

Focosi, Daniele; Franchini, Massimo

Focosi, Daniele; Franchini, Massimo.

Focosi D; North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
Franchini M; Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua, Italy.

Rev Med Virol ; 32(4): e2341, 2022 07.

Article in English | MEDLINE | ID: covidwho-1739230

Subject(s)

COVID-19; Antibodies, Viral/therapeutic use; COVID-19/therapy; Humans; Immunization, Passive; Immunoglobulins/therapeutic use; SARS-CoV-2

Keywords

COVID19; SARS-CoV-2; immunosuppressants; intravenous immunoglobulins; polyclonal antibodies

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Rev Med Virol Journal subject: Virology Year: 2022 Document Type: Article Affiliation country: Rmv.2341

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google